Hi-Acts News & Events

The ErUM-Data Transfer Workshop 2026 at Startup Labs Bahrenfeld brought together researchers and industry representatives from across Germany. The event focused on current developments in computing, artificial intelligence, and research software, while fostering exchange between science and industry. It provided a valuable platform for networking, knowledge transfer, and the development of new collaborations.

TWO DAYS. ONE INNOVATION CYCLE. Through the Helmholtz Tech & Industry Day 2026 and the Innovation Challenge Arena, Hi-Acts brought together stakeholders from research, industry, and policy – from strategic discussions on future technologies to the co-creation of concrete innovation ideas. Together, the two events demonstrated how dialogue creates partnerships and how ideas can evolve into future collaborations. Read More:

The Schleswig-Holsteinische Bildverarbeitungstage 2026 brought together more than 50 experts from industry, research, and academia at DESY in Hamburg to exchange ideas on the latest developments in imaging and machine vision. Highlights included talks on cutting-edge imaging technologies, industrial applications, and the presentation of the Fokusfinder Awards for outstanding academic theses. Read more about the event and its highlights!

During the 3rd Hi-Acts Network Meeting on June 10, five innovation challenges will be presented, bringing together researchers, industry representatives, and technology experts to collaborate on real-world problems. The focus is on challenges with strong application and technology transfer potential. Explore the challenges, connect with experts, and contribute your ideas to future technologies for research and industry. Discover the Challenges!

Hi-Acts presented its work at the CDU/CSU Innovation Congress in the German Bundestag, highlighting key applications of accelerator technologies. Experts from HZDR showcased advances in personalized medicine and semiconductor technologies, attracting strong political interest. The event emphasized the importance of exchange between science and policymaking.

Researchers at GSI Helmholtz Centre have developed a new Galactic Cosmic Ray Simulator that recreates the complex radiation environment of deep space in the laboratory. The accelerator-based system allows scientists to study how cosmic radiation affects astronauts, electronics, and shielding materials. The technology provides crucial insights for future missions to the Moon, Mars, and beyond. Read more.

From environmental protection to next-generation cancer therapies: the Competence Center for Radiation Research connects interdisciplinary science with accelerator-based technologies. Together with Hi-Acts, the platform aims to turn research into societal impact Discover the new initiative.

Minister Dirk Panter’s visit to HZDR highlights the importance of strong partnerships for advancing radiopharmacy. Hi-Acts supports the development of the nukliD network, connecting excellent research with industrial partners and clinical expertise. Together, we accelerate the translation of radiopharmaceutical innovation from the lab to real-world medical applications.

OSHOP 2025 brought together experts from research, industry, and the maker community. With talks, workshops, and live demonstrators, the conference offered valuable insights into the latest developments in open-source hardware.

Turning research into industrial advantage: The Hi-Acts webinar with Scatterin and DESY demonstrated how synchrotron X-ray diffraction can help improve materials, processes, and product performance — bridging science and industry for innovation.

In just three years, the Helmholtz innovation platform has built over 100 partnerships, launched numerous collaborations, and secured millions in funding. An independent review now confirms its success and strong future potential.

At the Hi-Tech meets Life Sciences Forum in Dresden, more than 120 experts from science, industry, and healthcare came together to strengthen Saxony’s radiopharmacy ecosystem. The two-day event showcased how high-tech and life sciences intersect—from research and production to clinical application and how Hi-Acts supports this innovation-driven collaboration.